J U Adelman

Summary

Country: USA

Publications

  1. ncbi Analysis of safety and tolerability data obtained from over 1,500 patients receiving topiramate for migraine prevention in controlled trials
    James Adelman
    Headache Wellness Center, Greensboro, North Carolina 27405, USA
    Pain Med 9:175-85. 2008
  2. ncbi Meta-analysis of oral triptan therapy for migraine: number needed to treat and relative cost to achieve relief within 2 hours
    James U Adelman
    Headache Wellness Center, 301 E Wendover Ave, Greensboro, NC 27401, USA
    J Manag Care Pharm 9:45-52. 2003
  3. ncbi Comparative aspects of triptans in treating migraine
    J U Adelman
    Department of Neurology, University of North Carolina, Chapel Hill, North Carolina, USA
    Clin Cornerstone 4:53-64. 2001
  4. ncbi Cost-effectiveness of antiepileptic drugs in migraine prophylaxis
    James U Adelman
    Headache Wellness Center, Greensboro, North Carolina, 27401, USA
    Headache 42:978-83. 2002
  5. ncbi Comparison of rizatriptan and other triptans on stringent measures of efficacy
    J U Adelman
    Headache Wellness Center, Greensboro, NC 27401, USA
    Neurology 57:1377-83. 2001
  6. ncbi Current options for the prevention and treatment of migraine
    J U Adelman
    Headache Wellness Center Greensboro, North Carolina 27401, USA
    Clin Ther 23:772-88; discussion 771. 2001
  7. ncbi Rizatriptan tablet versus wafer: patient preference
    J U Adelman
    Headache Wellness Center, Greensboro, NC 27403, USA
    Headache 40:371-2. 2000
  8. ncbi Oral narcotic protocol to reduce narcotic injections in refractory migraine patients
    R L Von Seggern
    Adelman Headache Center, Greensboro, NC 27403, USA
    Headache 37:341-5. 1997
  9. ncbi Cost considerations in headache treatment. Part 2: Acute migraine treatment
    R L Von Seggern
    Adelman Headache Center, Greensboro, NC 27403, USA
    Headache 36:493-502. 1996
  10. ncbi Cost considerations in headache treatment. Part 1: Prophylactic migraine treatment
    J U Adelman
    Adelman Headache Center, Greensboro, NC 27403, USA
    Headache 35:479-87. 1995

Detail Information

Publications19

  1. ncbi Analysis of safety and tolerability data obtained from over 1,500 patients receiving topiramate for migraine prevention in controlled trials
    James Adelman
    Headache Wellness Center, Greensboro, North Carolina 27405, USA
    Pain Med 9:175-85. 2008
    ....
  2. ncbi Meta-analysis of oral triptan therapy for migraine: number needed to treat and relative cost to achieve relief within 2 hours
    James U Adelman
    Headache Wellness Center, 301 E Wendover Ave, Greensboro, NC 27401, USA
    J Manag Care Pharm 9:45-52. 2003
    ..To determine the cost-effectiveness of the 5-HT1B/1D agonists, or triptans, in the acute treatment of migraine...
  3. ncbi Comparative aspects of triptans in treating migraine
    J U Adelman
    Department of Neurology, University of North Carolina, Chapel Hill, North Carolina, USA
    Clin Cornerstone 4:53-64. 2001
    ..The many triptans available offer the opportunity to individualize migraine treatment, depending on the patient's attack characteristics, tolerance, and preferences...
  4. ncbi Cost-effectiveness of antiepileptic drugs in migraine prophylaxis
    James U Adelman
    Headache Wellness Center, Greensboro, North Carolina, 27401, USA
    Headache 42:978-83. 2002
    ..To analyze the cost-effectiveness of antiepileptics in migraine prophylaxis...
  5. ncbi Comparison of rizatriptan and other triptans on stringent measures of efficacy
    J U Adelman
    Headache Wellness Center, Greensboro, NC 27401, USA
    Neurology 57:1377-83. 2001
    ..To compare the efficacy of oral rizatriptan 10 mg with oral doses of sumatriptan, naratriptan, and zolmitriptan on stringent outcome measures...
  6. ncbi Current options for the prevention and treatment of migraine
    J U Adelman
    Headache Wellness Center Greensboro, North Carolina 27401, USA
    Clin Ther 23:772-88; discussion 771. 2001
    ..Migraine is a common condition affecting approximately 18% of women and 6% of men in the United States. The goals of managing migraine are 2-fold: to prevent attacks from occurring and to effectively and rapidly end them when they do occur...
  7. ncbi Rizatriptan tablet versus wafer: patient preference
    J U Adelman
    Headache Wellness Center, Greensboro, NC 27403, USA
    Headache 40:371-2. 2000
    ..Of the 367 patients studied, 188 selected the oral disintegrating tablet, while 179 preferred the conventional tablet. Although individual patients had strong preferences for one preparation over the other, no group preference was found...
  8. ncbi Oral narcotic protocol to reduce narcotic injections in refractory migraine patients
    R L Von Seggern
    Adelman Headache Center, Greensboro, NC 27403, USA
    Headache 37:341-5. 1997
    ..This was offset by an oral narcotic protocol medication cost of only $392. This treatment method has been well accepted by patients and has proven to be a safe and cost-effective approach to treating refractory migraine patients...
  9. ncbi Cost considerations in headache treatment. Part 2: Acute migraine treatment
    R L Von Seggern
    Adelman Headache Center, Greensboro, NC 27403, USA
    Headache 36:493-502. 1996
    ..Sophisticated comparative studies are needed to evaluate, not only the direct costs of medications, but all costs of treatment of an acute migraine attack, as well as indirect costs to the patient, family, and society...
  10. ncbi Cost considerations in headache treatment. Part 1: Prophylactic migraine treatment
    J U Adelman
    Adelman Headache Center, Greensboro, NC 27403, USA
    Headache 35:479-87. 1995
    ..62/month). Better information is needed concerning effectiveness and optimal dosing of some older low-cost medications in the preventive treatment of migraine...
  11. ncbi Almotriptan versus sumatriptan in migraine treatment: direct medical costs of managing adverse chest symptoms
    Lisa K Mannix
    Headache Wellness Center, Greensboro, North Carolina, USA
    Am J Manag Care 8:S94-101. 2002
    ..64 for patients treated with sumatriptan, a difference of $1.42 per patient. CONCLUSION: Relative to sumatriptan, treatment with almotriptan is likely to reduce patient care costs associated with chest symptom adverse events...
  12. ncbi Venlafaxine extended release (XR) for the prophylaxis of migraine and tension-type headache: A retrospective study in a clinical setting
    L C Adelman
    Headache Wellness Center, Greensboro, NC 27403, USA
    Headache 40:572-80. 2000
    ..We recommend a double-blind, placebo-controlled study to further assess the role of extended-release venlafaxine in headache prevention...
  13. ncbi Efficacy of topiramate in migraine prophylaxis: a retrospective chart analysis
    Randal L Von Seggern
    Headache Wellness Center, Greensboro, North Carolina 27401, USA
    Headache 42:804-9. 2002
    ..In particular, topiramate may offer relief to patients with moderate/severe migraines who do not respond to other treatments...
  14. ncbi The effect of early intervention with sumatriptan tablets on migraine-associated productivity loss
    W Jacqueline Kwong
    GlaxoSmithKline, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
    J Occup Environ Med 47:1167-73. 2005
    ..This analysis examined productivity loss as a result of migraine after treatment with sumatriptan tablets and patients' usual non-triptan therapy when pain was mild (early intervention) versus when pain was moderate/severe...
  15. ncbi Cost considerations of acute migraine treatment
    James U Adelman
    Headache Wellness Center, Greensboro, NC 27401, USA
    Headache 44:271-85. 2004
    ..89 dollars. CONCLUSIONS: Practitioners can optimize the use of health care dollars without compromising quality of care through awareness of cost-saving treatment strategies, as well as price variations among medications...
  16. ncbi A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine
    James U Adelman
    Neurology 64:931; author reply 931. 2005
  17. ncbi Meta-analysis methodology: the battle continues
    Jonathan Belsey
    Headache 43:1119-21; author reply 1121. 2003
  18. ncbi Sumatriptan-naproxen for acute treatment of migraine: a randomized trial
    Jan Lewis Brandes
    Nashville Neuroscience Group, Nashville, Tenn 37203, USA
    JAMA 297:1443-54. 2007
    ..Multiple pathogenic mechanisms may be involved in generating the migraine symptom complex, and multimechanism-targeted therapy may confer advantages over monotherapy...
  19. ncbi Does migraine preventive medication actually reduce resource utilization?
    James U Adelman
    Headache 43:1116-8; author reply 1118. 2003